Primorye's ankylosing spondylitis patients face life-altering drug shortage until December

Patients in Primorye Territory afflicted with Ankylosing Spondylitis have been left without a crucial free medication. The drug, vital for managing severe pain and preventing spinal rigidity, is currently unavailable in the region. Local authorities have now taken steps to resolve the shortage.

The crisis came to light after VL.ru News reported the scarcity of the medication in local pharmacies. The high cost and limited supply have forced 35 registered patients to seek alternatives while waiting for restocking.

Primorye's Ministry of Health confirmed the shortage and revealed that a new shipment is expected by December 10. A contract for the delivery was signed on November 24, 2024, ensuring supplies until February 2025. However, the ministry had initially allocated 33 million rubles for 2025, only to find demand exceeding projections.

To bridge the gap, officials have requested an extra 3.6 million rubles. In the meantime, doctors may prescribe alternative immunosuppressants with different active ingredients. These substitutes can help control symptoms but may not be as effective for all patients.

Ankylosing Spondylitis is a chronic inflammatory disease that targets spinal joints. Without proper treatment, it can lead to irreversible spinal stiffness and total loss of mobility.

The medication remains unavailable until the new batch arrives in December. Once restocked, it will cover patient needs for at least two months. Regional health authorities continue to monitor the situation to prevent future shortages.